Reclipsen (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Reclipsen drug offered from Actavis Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Desogestrel and Ethinyl Estradiol |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Reclipsen HUMAN PRESCRIPTION DRUG Details:
| Item Description | Reclipsen from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2005-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52544-954_65f2bbf9-0b62-4c26-8651-9c662b91fe4b |
| PRODUCT NDC: | 52544-954 |
| APPLICATION NUMBER: | ANDA076915 |